Long Frozen Storage Limited the Precision of a Residual-THC Study

A residual-THC study acknowledged that whole-blood specimens had been stored frozen for up to five years before analysis. Possible analyte loss limits interpretation of the original concentration, but it is a different issue from whether THC remained measurable in a collected specimen.

The limitation concerned stored whole blood

Karschner and colleagues reported serial cannabinoid findings during monitored abstinence in frequent users. Their discussion identified long-term frozen storage as a limitation, including possible adsorption, precipitation with proteins or degradation.

The authors considered these processes potential sources of underestimation. That interpretation concerns the measured concentration relative to the concentration at collection; it does not create a known percentage correction for every sample.

Fortified samples did not recreate every authentic specimen

The paper discussed differing stability findings from studies using fortified blood. It explicitly distinguished those experiments from the authentic specimens in its own study.

Adding a known cannabinoid amount to blank blood can help investigate stability, but the result does not automatically reproduce every binding, storage and matrix characteristic of blood collected from a participant. Temperature alone does not define the entire storage history.

Separate persistence from exact reconstruction

A possible loss process does not erase a reported positive after several days of observed abstinence. It does restrict claims about the exact concentration originally present and comparisons across storage conditions.

The study does not establish that all stored specimens change equally or that a later analyst can restore the original value mathematically. A case interpretation should state the specimen, storage interval and demonstrated method limits without applying an invented recovery factor. None of these analytical considerations establishes functional impairment.

Related: Separating cannabis exposure from impairment.

Research cited

Karschner EL; Schwilke EW; Lowe RH; et al.. Addiction (2009). Do delta-9-tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users?.